Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

27.16
-0.9800-3.48%
Post-market: 27.170.0100+0.04%19:59 EDT
Volume:15.70M
Turnover:428.25M
Market Cap:10.61B
PE:-3.61
High:27.87
Open:27.83
Low:26.87
Close:28.14
52wk High:56.70
52wk Low:23.15
Shares:390.58M
Float Shares:363.29M
Volume Ratio:0.99
T/O Rate:4.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5273
EPS(LYR):-9.2734
ROE:-27.50%
ROA:-14.78%
PB:1.13
PE(LYR):-2.93

Loading ...

Moderna ‘checking another mark’ in oncology franchise, says Wolfe Research

TIPRANKS
·
Oct 18

Moderna Inc Shares Down 4.3% at $25.96

THOMSON REUTERS
·
Oct 18

Moderna sees 5-year follow up from Phase 2 study in 2026

TIPRANKS
·
Oct 18

Moderna down 4.2% after publishing results on mRNA-4359 plus pembrolizumab

TIPRANKS
·
Oct 18

Moderna Inc. Publishes Trial Results on mRNA-4359 Plus Pembrolizumab in Checkpoint Inhibitor-Resistant Melanoma

Reuters
·
Oct 17

Moderna Inc. Stock Advances 5.5%, Outperforms Peers

Dow Jones
·
Oct 16

Leerink Partners Adjusts Price Target on Moderna to $16 From $15, Maintains Underperform Rating

MT Newswires Live
·
Oct 15

Mixed options sentiment in Moderna with shares down 0.79%

TIPRANKS
·
Oct 14

BUZZ-Novavax falls as top investor urges sale over poor COVID shot rollout

Reuters
·
Oct 14

Moderna announces promising early clinical data for mRNA4359 cancer antigen therapy at ESMO 2025

Reuters
·
Oct 13

BRIEF-Moderna Says It Presents Promising Early Data For Investigational Cancer Antigen Therapy

Reuters
·
Oct 13

Moderna: Presents Promising Early Data for Investigational Cancer Antigen Therapy

THOMSON REUTERS
·
Oct 13

Moderna: Mrna-4359 in Combination With Pembrolizumab Showed Consistently Manageable Safety Profile, No New Immune-Related Adverse Events

THOMSON REUTERS
·
Oct 13

Moderna: Mrna-4359 Has Advanced Into Phase 2 Portion of Ongoing Phase 1/2 Trial

THOMSON REUTERS
·
Oct 13

RBC Capital Sticks to Its Hold Rating for Moderna (MRNA)

TIPRANKS
·
Oct 10

Veeva Systems Inc to Attend Veeva Commercial Summit Europe in Madrid

Reuters
·
Oct 10

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09

Updated COVID shot led to less severe illness, fewer hospitalizations last year, US study finds

Reuters
·
Oct 09

Stock Track | Moderna Soars 7.05% as CDC Updates COVID Vaccination Guidelines

Stock Track
·
Oct 08

US Stock Movement | Moderna, Inc. (MRNA.US) Surges Over 6.7% Following CDC's New Guidelines Making COVID Vaccination an Individual Decision

Stock News
·
Oct 08